No Data
No Data
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $12
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Express News | GeoVax Receives Notice of Allowance for Cancer Vaccine Patent
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Buddahs World : awesome post man thank you !
michael_11 : Is it a good thing to have a small amount of outstanding shares?
70065450 : It is a good thing.
Jaguar8 OP michael_11 : Yes mostly because it increases EPS, less dilution risk, and gives more value to shareholders and attractive to investors. Drawback is it has higher volatility and lesser liquidity
T_Kale : Thank you for taking the time to do this!
View more comments...